These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17721002)

  • 21. Efflux pumps in drug resistance of Candida.
    Prasad R; Gaur NA; Gaur M; Komath SS
    Infect Disord Drug Targets; 2006 Jun; 6(2):69-83. PubMed ID: 16789872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yeast ATP-binding cassette transporters conferring multidrug resistance.
    Prasad R; Goffeau A
    Annu Rev Microbiol; 2012; 66():39-63. PubMed ID: 22703054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing the fungicidal activity of amphotericin B via vacuole disruption by benzyl isothiocyanate, a cruciferous plant constituent.
    Yamada N; Murata W; Yamaguchi Y; Fujita KI; Ogita A; Tanaka T
    Lett Appl Microbiol; 2021 Apr; 72(4):390-398. PubMed ID: 33128810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABC transporters coupled with the elevated ergosterol contents contribute to the azole resistance and amphotericin B susceptibility.
    Ren B; Dai HQ; Pei G; Tong YJ; Zhuo Y; Yang N; Su MY; Huang P; Yang YZ; Zhang LX
    Appl Microbiol Biotechnol; 2014 Mar; 98(6):2609-16. PubMed ID: 24435642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amphotericin B-copper(II) complex shows improved therapeutic index in vitro.
    Chudzik B; Czernel G; Miaskowski A; Gagoś M
    Eur J Pharm Sci; 2017 Jan; 97():9-21. PubMed ID: 27816628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
    Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
    Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans.
    Prasad T; Saini P; Gaur NA; Vishwakarma RA; Khan LA; Haq QM; Prasad R
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3442-52. PubMed ID: 16048959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
    J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
    Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dependence of vacuole disruption and independence of potassium ion efflux in fungicidal activity induced by combination of amphotericin B and allicin against Saccharomyces cerevisiae.
    Ogita A; Yutani M; Fujita K; Tanaka T
    J Antibiot (Tokyo); 2010 Dec; 63(12):689-92. PubMed ID: 20940723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans.
    Lo HJ; Tseng KY; Kao YY; Tsao MY; Lo HL; Yang YL
    Int J Antimicrob Agents; 2015 Jun; 45(6):617-21. PubMed ID: 25802233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing the Fungicidal Action of Amphotericin B by Inhibiting the Nitric Oxide-Dependent Tolerance Pathway.
    Vriens K; Kumar PT; Struyfs C; Cools TL; Spincemaille P; Kokalj T; Sampaio-Marques B; Ludovico P; Lammertyn J; Cammue BPA; Thevissen K
    Oxid Med Cell Longev; 2017; 2017():4064628. PubMed ID: 29129987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
    Lignell A; Löwdin E; Cars O; Sjölin J
    J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphotericin B-copper(II) complex as a potential agent with higher antifungal activity against Candida albicans.
    Chudzik B; Tracz IB; Czernel G; Fiołka MJ; Borsuk G; Gagoś M
    Eur J Pharm Sci; 2013 Aug; 49(5):850-7. PubMed ID: 23791641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CaALK8, an alkane assimilating cytochrome P450, confers multidrug resistance when expressed in a hypersensitive strain of Candida albicans.
    Panwar SL; Krishnamurthy S; Gupta V; Alarco AM; Raymond M; Sanglard D; Prasad R
    Yeast; 2001 Sep; 18(12):1117-29. PubMed ID: 11536334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo characterization of the drug resistance profile of the major ABC transporters and other components of the yeast pleiotropic drug resistance network.
    Kolaczkowski M; Kolaczowska A; Luczynski J; Witek S; Goffeau A
    Microb Drug Resist; 1998; 4(3):143-58. PubMed ID: 9818966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro.
    Perez AP; Altube MJ; Schilrreff P; Apezteguia G; Celes FS; Zacchino S; de Oliveira CI; Romero EL; Morilla MJ
    Colloids Surf B Biointerfaces; 2016 Mar; 139():190-8. PubMed ID: 26709977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New N-alkyl derivatives of amphotericin B. Synthesis and biological properties.
    Czerwiński A; König WA; Zieniawa T; Sowiński P; Sinnwell V; Milewski S; Borowski E
    J Antibiot (Tokyo); 1991 Sep; 44(9):979-84. PubMed ID: 1938621
    [No Abstract]   [Full Text] [Related]  

  • 40. Learning the ABC of oral fungal drug resistance.
    Cannon RD; Holmes AR
    Mol Oral Microbiol; 2015 Dec; 30(6):425-37. PubMed ID: 26042641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.